These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24788802)
1. The 8th International Congress on Cutaneous Adverse Drug Reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions. Dodiuk-Gad RP; Chung WH; Yang CH; Lu CW; Hui RC; Shear NH Drug Saf; 2014 Jun; 37(6):459-64. PubMed ID: 24788802 [No Abstract] [Full Text] [Related]
2. The 10th International Congress on Cutaneous Adverse Drug Reactions, Shimane, Japan, 2018: Focus on New Discoveries. Olteanu C; Shear NH; Morita E; Chung WH; Niihara H; Matsukura S; Hashimoto R; Dodiuk-Gad RP Drug Saf; 2019 Jun; 42(6):797-801. PubMed ID: 31037651 [No Abstract] [Full Text] [Related]
3. The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015. Dodiuk-Gad RP; Olteanu C; Chung WH; Shear NH Drug Saf; 2016 Mar; 39(3):271-6. PubMed ID: 26798049 [No Abstract] [Full Text] [Related]
4. New Discoveries and Updates on Cutaneous Adverse Drug Reactions Presented at the 24th World Congress of Dermatology, Milan, Italy, 2019. Chan FL; Shear NH; Shah N; Olteanu C; Hashimoto R; Dodiuk-Gad RP Drug Saf; 2020 Feb; 43(2):179-187. PubMed ID: 31673951 [No Abstract] [Full Text] [Related]
5. Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis. Deng Q; Fang X; Zeng Q; Lu J; Jing C; Huang J An Bras Dermatol; 2017; 92(3):345-349. PubMed ID: 29186246 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of severe cutaneous adverse reactions. Kaniwa N; Saito Y Pharmacogenomics; 2013 Apr; 14(6):595-8. PubMed ID: 23570461 [No Abstract] [Full Text] [Related]
7. Cutaneous reactions to drugs. Rubeiz NG; Sharif MA; Kibbi AG Middle East J Anaesthesiol; 1991 Jun; 11(2):147-62. PubMed ID: 1745207 [No Abstract] [Full Text] [Related]
8. Adverse cutaneous reactions to medications. Kroshinsky D Clin Dermatol; 2020; 38(6):605-606. PubMed ID: 33341194 [No Abstract] [Full Text] [Related]
9. Recognising severe cutaneous adverse drug reactions. Chee P Med J Aust; 2017 Oct; 207(8):325-327. PubMed ID: 29020897 [No Abstract] [Full Text] [Related]
10. Patch testing in cutaneous adverse drug reactions: methodology, interpretation, and clinical relevance. Mahajan VK; Handa S Indian J Dermatol Venereol Leprol; 2013; 79(6):836-41. PubMed ID: 24177628 [No Abstract] [Full Text] [Related]
11. Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach. Tan-Koi WC; Sung C; Chong YY; Lateef A; Pang SM; Vasudevan A; Aw D; Lui NL; Lee SX; Ren EC; Koay ES; Tay YK; Lim YL; Lee HY; Dong D; Loke C; Tan L; Limenta M; Lee EJ; Toh D; Chan CL Pharmacogenomics; 2017 Jun; 18(9):881-890. PubMed ID: 28594314 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review. Macklis PC; Dulmage B; Evans B; Rosenbach M; Gudjonsson JE; Kaffenberger BH Drugs R D; 2020 Sep; 20(3):171-187. PubMed ID: 32557274 [TBL] [Abstract][Full Text] [Related]
14. Severe drug-induced dermatoses. Ahronowitz I; Fox L Semin Cutan Med Surg; 2014 Mar; 33(1):49-58. PubMed ID: 25037258 [TBL] [Abstract][Full Text] [Related]
15. Cutaneous drug reaction case reports. From the world literature. Am J Clin Dermatol; 2001; 2(5):335-44. PubMed ID: 11721652 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous drug reaction case reports from the world literature. Am J Clin Dermatol; 2001; 2(2):121-7. PubMed ID: 11712524 [TBL] [Abstract][Full Text] [Related]